Training of Arms to Reduce Pain With Peripheral Venous Catheter

Sponsor
Vejle Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05716217
Collaborator
(none)
84
1
2
34.3
2.4

Study Details

Study Description

Brief Summary

Female patients undergoing chemotherapy for breast cancer often experience pain and discomfort when a peripheral venous catheter is inserted.

This randomized, controlled trial investigates whether there is a difference in the degree of pain during PVC insertion in patients who exercise their arms, and whether exercise improves vein status.

Participation involves:
  • Everyone must have had their peripheral venous catheter (PVC) inserted at least five times in the DROP-IN, which is an outpatient clinic staffed by anesthesia nurses who are specialists in applying PVCs.

  • Everyone will three times be asked to answer some questions in the DROP-IN, have their grip strength measured in both hands, and have the course of the veins in their arms clarified.

  • The training group must do arm training exercises daily for at least eight weeks (training equipment is provided)

  • Ten participants will at the end of the project period be invited to participate in a telephone interview about experiences of vein status during a cancer treatment course.

Condition or Disease Intervention/Treatment Phase
  • Other: Arm training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
One group is randomly assigned to an 8-week daily arm training program. The other group receives normal careOne group is randomly assigned to an 8-week daily arm training program. The other group receives normal care
Masking:
Single (Care Provider)
Masking Description:
The anaesthesia nurses inserting PVCs and registering data are blinded to the participants' study allocation.
Primary Purpose:
Treatment
Official Title:
Can Training of the Armsy Reduce Pain When Inserting a Peripheral Venous Catheter, and How is it Experienced That There Can be Challenges With Vein Status for Patients in Cytostatic Treatment?
Anticipated Study Start Date :
Feb 20, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training group

Other: Arm training
Daily arm training program

No Intervention: Normal care

Outcome Measures

Primary Outcome Measures

  1. Level of pain as measure by the Numeric Rating Scale (score 1-10 where a low value defines low level of pain) [Measured at baseline]

    Pain level after insertion of periphral venous catheter and at general activity measured with Numeric Rating Scale

  2. Level of pain as measure by the Numeric Rating Scale (score 1-10 where a low value defines low level of pain) [Measured after five weeks of training/control]

    Pain level after insertion of periphral venous catheter and at general activity measured with Numeric Rating Scale

  3. Level of pain as measure by the Numeric Rating Scale (score 1-10 where a low value defines low level of pain) [Measured after eight weeks of training/control]

    Pain level after insertion of periphral venous catheter and at general activity measured with Numeric Rating Scale

Secondary Outcome Measures

  1. Vein status [Measured at baseline]

    Number of useable veins (assessed via ultrasound)

  2. Vein status [Measured after five weeks of training/controll]

    Number of useable veins (assessed via ultrasound)

  3. Vein status [Measured after eight weeks of training/control]

    Number of useable veins (assessed via ultrasound)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Planned neoadjuvant or adjuvant chemotherapy via intravenous peripheral venous cannula placed under ultrasound guidance

  • PVC insertion is performed in the DROP-IN outpatient clinic, Department of Anesthesiology, Vejle Hospital, at least four times

  • The patient has provided written and orally informed consent

  • The patient must be cognitively well preserved and able to understand information

Exclusion Criteria:
  • Patients who cannot read and understand Danish

  • Patients <18 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vejle Hospital Vejle Southern Jutland Denmark 7100

Sponsors and Collaborators

  • Vejle Hospital

Investigators

  • Study Chair: Hanne I Jensen, PhD, Vejle Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT05716217
Other Study ID Numbers:
  • Vein-project
First Posted:
Feb 8, 2023
Last Update Posted:
Feb 8, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Feb 8, 2023